Skip to main content
SpringerLink
Log in

Management of Cardiac Arrhythmias during Pregnancy

Current Concepts

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Cardiac arrhythmia is one of the most common reasons for cardiac consultation during pregnancy. Fortunately, malignant arrhythmias during the course of normal gestation are rare, and the relatively common complaint of palpitations is usually due to benign arrhythmias. However, in pregnant patients with organic heart disease, arrhythmias are often triggered by the haemodynamic burden of pregnancy and may be the first manifestalion of the disease. In addition, rhythm abnormalities in patients with limited cardiac reserves may have significant haemodynamic consequences and can compromise fetal well-being.

Any woman who presents with rhythm disorders during pregnancy should undergo a diagnostic evaluation to rule out an underlying disease, including cardiac, pulmonary, endocrine, or metabolic disease. Additionally, removal of precipitating factors, such as excessive ingestion of caffeine and/or alcohol, cigarette smoking, drug abuse or therapy with arrhythmogenic compounds, is indicated (as these measures are desirable in any pregnant woman). Antiarrhythmic drug therapy is indicated in such patients only in symptomatic or haemodynamically significant arrhythmias.

In cases where organic heart disease or any other cause for arrhythmia is identified, the underlying disease should be treated first. Antiarrhythmic drug therapy is indicated when arrhythmias persist or as a prophylactic measure.

In principle, the approach to drug therapy in pregnant patients is similar to that in non-pregnant patients. However, special consideration should be given to drug selection in order to avoid adverse effects to the fetus. Those antiarrhythmics that have been shown to be relatively safe during pregnancy include digoxin, quinidine, procainamide, some β -blocking drugs and lignocaine (lidocaine). In addition to careful drug selection, the smallest effective dose should be used and the indication for antiarrhythmic therapy should be periodically reassessed during the course of pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allen RW, Ogden B, Bently FL, Jang AL. Fetal hydantoin syndrome, neuroblastoma and hemorrhagic disease in a neonate. Journal of the American Medical Association 244: 1464–1465, 1980

    Article  PubMed  Google Scholar 

  • Allonen H, Kanto J, Iisalo E. The foeto-maternal distribution of digoxin in early human pregnancy. Acta Pharmacologica Tox-icologica 39: 477–480, 1976

    Article  CAS  Google Scholar 

  • Barrillon A, Grand A, Gerbaux A. Treatment of the heart during pregnancy. Annales de Medecine Interne (Paris) 125: 437–445, 1974

    CAS  Google Scholar 

  • Bellet S. Essentials of cardiac arrhythmias: diagnosis and management. W.B. Saunders Co., Philadelphia, 1972

    Google Scholar 

  • Bharati S, Rosen K, Steinfield L, Miller RA, Lev M. The anatomic substrate for pre-excitation in corrected transposition. Circulation 62: 831–842, 1980

    Article  PubMed  CAS  Google Scholar 

  • Biehl D, Shnider SM, Levinson S, Callender K. Placental transfer of lidocaine. Anesthesiology 48: 409–412, 1978

    Article  PubMed  CAS  Google Scholar 

  • Blattner WA, Henson DE, Young RC, Fraumeni Jr JF. Malignant mesenchymoma and birth defects: prenatal exposure to phenytoin. Journal of the American Medical Association 238: 334–335, 1977

    Article  PubMed  CAS  Google Scholar 

  • Brown WW, Bell GG, Alper MH. Acidosis, local anesthesia and newborn. Obstetrics and Gynecology 48: 23–30, 1976

    Google Scholar 

  • Brown WV, Bell GC, Luri AO, Weiss JB, Scalon JW, et al. Newborn blood levels of lidocaine and mepivacaine in the first postnatal day following maternal epidural anesthesia. Anesthesiology 42: 698–707, 1975

    Article  PubMed  CAS  Google Scholar 

  • Candelpergher G, Buchberger R, Suzzi G, Padrini R. Transplacental passage of amiodarone: Electrocardiographic evidence and pharmacological findings in a newborn infant. Giornale Italiano di Cardiologica 12: 79–82, 1982

    CAS  Google Scholar 

  • Colin A, Lambotte R. Influence teratogene des medicaments administres a la femme enceinte. Revue Medicale de Liège 27(Suppl. 1): 39–48, 1972

    PubMed  Google Scholar 

  • Cottrill CM, McAllister RG, Gettes L, Noonan JA. Propranolol therapy during pregnancy, labor and delivery: evidence for impaired neonatal drug disposition. Journal of Pediatrics 91: 812–814, 1977

    Article  PubMed  CAS  Google Scholar 

  • Cupit GC, Rotmensch HH. Principles of drug therapy in pregnancy. In Gleicher N (Ed.), Principles of medical therapy in pregnancy, pp. 77–90, Plenum Medical Book Company, New York, London, 1985

    Chapter  Google Scholar 

  • Curry JJ, Quintana F. Myocardial infarction with ventricular fibrillation during pregnancy treated by direct current defibrillation with fetal survival. Chest 58: 82–84, 1970

    Article  PubMed  CAS  Google Scholar 

  • Devlin RG, Duchin KL, Fleiss PM. Nadolol in human serum and breast milk. British Journal of Clinical Pharmacology 12: 393–396, 1981

    Article  PubMed  CAS  Google Scholar 

  • Dumesic DA, Silverman NH, Tobias S, Golbus MS. Transplacental cardioversion of fetal supraventricular tachycardia with procainamide. New England Journal of Medicine 307: 1128–1131, 1982

    Article  PubMed  CAS  Google Scholar 

  • Evans AR, Forrester RM, Discombo C. Neonatal hemorrhage following maternal anticonvulsant therapy. Lancet 1: 517–518, 1970

    Article  PubMed  CAS  Google Scholar 

  • Gladstone GR, Hordof A, Gersong WM. Propranolol administration during pregnancy: effects on the fetus. Journal of Pediatrics 86: 962–964, 1975

    Article  PubMed  CAS  Google Scholar 

  • Gleicher N, Meller J, Sandier RZ, Sullum S. Wolff-Parkinson-White syndrome in pregnancy. American Journal of Obstetrics and Gynecology 58: 748–752, 1981

    CAS  Google Scholar 

  • Grand A, Bernard J. Cardioversion et grossesse: consequences foetales. Nouvelle Presse Medicale 2: 2327–2329, 1973

    PubMed  CAS  Google Scholar 

  • Habib A, McCarthy JS. Effects on the neonate of propranolol administered during pregnancy. Journal of Pediatrics 91: 808–811, 1977

    Article  PubMed  CAS  Google Scholar 

  • Hanson JW, Myrianthopoulos NC, Harvey MAS, Smith DW. Risks of offspring of women treated with hydantoin anticonvulsant and emphasis of fetal hydantoin syndrome. Journal of Pediatrics 89: 662–668, 1976

    Article  PubMed  CAS  Google Scholar 

  • Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. PSG Pub, Littleton, Massachusetts, 1977

    Google Scholar 

  • Hill LM, Malkasian GD. The use of quinidine sulfate throughout pregnancy. Obstetrics and Gynecology 54: 366–368, 1979

    PubMed  CAS  Google Scholar 

  • Karim A, Cook C, Campion J. Placental and milk transfer of disopyramide and its metabolites in rats. Drug Metabolism and Disposition 6: 346–348, 1978

    PubMed  CAS  Google Scholar 

  • Klein HO, Kaplinsky E. Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction. American Journal of Cardiology 50: 894–902, 1982

    Article  PubMed  CAS  Google Scholar 

  • Klein V, Repke J. Supraventricular tachycardia in pregnancy: cardioversion with verapamil. Obstetrics and Gynecology 63: 165–185, 1984

    Google Scholar 

  • Lamming GD, Seymonds EB. Use of labetalol and methyldopa in pregnancy-induced hypertension. British Journal of Clinical Pharmacology 8(Suppl. 2): 217S–222S, 1979

    PubMed  CAS  Google Scholar 

  • Leonard RF, Braun TE, Levy AM. Initiation of uterine contractions by disopyramide during pregnancy. New England Journal of Medicine 299: 84–85, 1978

    Article  PubMed  CAS  Google Scholar 

  • Levy M, Granit L, Laufer N. Excretion of drugs in human milk. New England Journal of Medicine 297: 789, 1977

    Article  PubMed  CAS  Google Scholar 

  • Liedholm H, Melander A, Bitzen P-O, Helm G, Lonnerholm G, et al. Accumulation of atenolol and metoprolol in human breast milk. European Journal of Clinical Pharmacology 20: 229–231, 1971

    Article  Google Scholar 

  • Lunell NO, Persson B, Aragon G, Fredholm BB, Astrom H. Circulatory and metabolic effects of acute beta-1 blockade in severe pre-eclampsia. Acta Obstetrica Gynecologica Scandinavica 58: 443–445, 1979

    Article  CAS  Google Scholar 

  • McKenna WJ, Harris L, Rowland E, Whitelaw A, Storey G, et al. Amiodarone therapy during pregnancy. American Journal of Cardiology 51: 1231–1233, 1983

    Article  PubMed  CAS  Google Scholar 

  • McMillan TM, Bellet S. Ventricular paroxysmal tachycardia: report of a case in a pregnant girl of sixteen years with an apparently normal heart. American Heart Journal 7: 70–71, 1931

    Article  Google Scholar 

  • Meitus ML. Fatal electrocardiography and cardioversion with direct current countershock. Diseases of the Chest 48: 324–325, 1965

    Article  PubMed  CAS  Google Scholar 

  • Melander A, Niklasson B, Ingermarsson I, Ledeholm H, Schersten B, et al. Transplacental passage of atenolol in man. European Journal of Clinical Pharmacology 14: 93–94, 1978

    Article  PubMed  CAS  Google Scholar 

  • Meller J, Goldman HE. Rhythm disorders and pregnancy. In El-kayam U & Gleicher N (Eds) Cardiac problems in pregnancy, diagnosis and management of maternal and fetal disease, pp. 167–178, Alan R. Liss, New York, 1982

    Google Scholar 

  • Mendelson CL. Disorders of the heartbeat during pregnancy. American Journal of Obstetrics and Gynecology 72: 1268–1301, 1956

    PubMed  CAS  Google Scholar 

  • Merx W. Herzrhythmusstorungen in der Schwangerschaft. Deutsche Medinizinische Wochenschrift 97: 1987–1988, 1972

    CAS  Google Scholar 

  • Meyer J, Lackner JE, Schochet SS. Paroxysmal tachycardia in pregnancy. Journal of the American Medical Association 94: 1901–1904, 1930

    Article  Google Scholar 

  • Michael CA. Use of labetalol in the treatment of severe hypertension during pregnancy. British Journal of Clinical Pharmacology 8(Suppl. 2): 211S–215S, 1979

    PubMed  CAS  Google Scholar 

  • Monson RR, Rosenberg L, Hartz SC, Shapiro S, Heinonen OP, et al. Diphenylhydantoin and selected congenital malformations. New England Journal of Medicine 289: 1049–1052, 1973

    Article  PubMed  CAS  Google Scholar 

  • O’Hare MF, Murnaghan GA, Russell CJ, Leahey WJ, Varma MPS, et al. Sotalol as a hypotensive agent in pregnancy. British Journal of Obstetrics and Gynaecology 87: 814–820, 1980

    Article  PubMed  Google Scholar 

  • Okita GT, Plotz EJ, Davis V. Placental transfer of radioactive digitoxin in pregnant women and its fetal distribution. Circulation Research 4: 376–380, 1956

    Article  PubMed  CAS  Google Scholar 

  • Penn IM, Barrett PA, Pannikote V, Barnaby P, Campbell JB, et al. Amiodarone in pregnancy. American Journal of Cardiology 56: 196–197, 1985

    Article  PubMed  CAS  Google Scholar 

  • Pinto Jr W, Gardner LI, Rosenbaum P. Abnormal genitalia as a presenting sign in two male infants with hydantoin embyropathy syndrome. American Journal of Diseases of Children 131: 452–455, 1977

    PubMed  Google Scholar 

  • Pitcher D, Leather HM, Storey GCA, Holt DW. Amiodarone in pregnancy. Lancet 1: 597–598, 1983

    Article  PubMed  CAS  Google Scholar 

  • Pitkin RM. Drugs in pregnancy. In Quilligan EJ & Kretchmer N (Eds) Fetal and maternal medicine, pp. 385–402, Wiley, New York, 1980

    Google Scholar 

  • Potondi A. Congenital rhabdomyoma of the heart and intrauterine digitalis poisoning. Journal of Forensic Science 11: 81–88, 1966

    CAS  Google Scholar 

  • Pruyn SC, Phelan JP, Buchanan GC. Long-term propranolol therapy in pregnancy: maternal and fetal outcome. American Journal of Obstetrics and Gynecology 135: 485–489, 1979

    PubMed  CAS  Google Scholar 

  • Robards GJ, Saunders PM. Refractory supraventricular tachycardia complicating pregnancy. Medical Journal of Australia 2: 278, 1973

    PubMed  CAS  Google Scholar 

  • Robson DJ, Jeeva-Raj MV, Storey GC, Holt DW. Use of amiodarone during pregnancy. Postgraduate Medical Journal 61: 75–77, 1985

    Article  PubMed  CAS  Google Scholar 

  • Rogers MC, Willerson JT, Goldblatt A, Smith TW. Serum digoxin concentrations in the human fetus, neonate and infant. New England Journal of Medicine 287: 1010–1013, 1972

    Article  PubMed  CAS  Google Scholar 

  • Roth A, Harrison E, Matani G, Cohen J, Rahimtoola SH, et al. Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation. Circulation 73: 316–324, 1986

    Article  PubMed  CAS  Google Scholar 

  • Sandstrom B. Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy. Gynecologic and Obstetric Investigations 9: 195–204, 1978

    Article  CAS  Google Scholar 

  • Schroeder JS, Harrison DC. Repeated cardioversion during pregnancy: treatment of refractory paroxysmal atrial tachycardia during three successive pregnancies. American Journal of Cardiology 27: 445–446, 1971

    Article  PubMed  CAS  Google Scholar 

  • Serafine PC, Petracco A, Vicosa Jr HM, Costa PL. Arterial hyposensitive effect of verapamil in severa pre-eclampsia. Preliminary study. Arquivos Brasilieros de Cardiologia 32: 57–61, 1979

    Google Scholar 

  • Shapiro S, Hortz SC, Siskind V, Mitchell AA, Slone D, et al. Anticonvulsants and parenteral epilepsy in the development of birth defects. Lancet 1: 272–275, 1976

    Article  PubMed  CAS  Google Scholar 

  • Shaxted EJ, Mitton PJ. Disopyramide in pregnancy: a case report. Current Medical Research and Opinion 6: 70–72, 1979

    Article  PubMed  CAS  Google Scholar 

  • Sherman JL, Locke RU. Transplacental neonate digitalis intoxication. American Journal of Cardiology 6: 834–837, 1960

    Article  Google Scholar 

  • Smith WM, Gallagher JJ, Kerr CR, Sealy WC, Kasell JH, et al. The electrophysiologic basis and management of symptomatic recurrent tachycardia in patient with Ebstein’s anomaly of the tricuspid valve. American Journal of Cardiology 49: 1223, 1982

    Article  PubMed  CAS  Google Scholar 

  • Soyka LF. Digoxin: placental transfer, effects on the fetus, and therapeutic use in the newborn. Clinics in Perinatology 2: 23–35, 1975

    PubMed  CAS  Google Scholar 

  • Sussman HI, Duque D, Lesser ME. Atrial flutter with 1: 1 conduction: report of a case in a pregnant woman successfully treated with DC countershock. Diseases of the Chest 49: 99–103, 1966

    Article  PubMed  CAS  Google Scholar 

  • Teuscher A, Bossi E, Imhof P. Effect of propranolol on fetal tachycardia in diabetic pregnancy. American Journal of Cardiology 42: 304–307, 1978

    Article  PubMed  CAS  Google Scholar 

  • Timmis AD, Jackson G, Holt DW. Mexiletine for control of ventricular dysrhythmias in pregnancy. Lancet 2: 647–648, 1980

    Article  PubMed  CAS  Google Scholar 

  • Truog WE, Feusner JH, Baker DL. Association of hemorrhagic disease and the syndrome of persistent fetal circulation with the fetal hydantoin syndrome. Journal of Pediatrics 96: 112–114, 1980

    Article  PubMed  CAS  Google Scholar 

  • Turnstall MB. The effect of propranolol on the onset of breathing at birth. Abstract. British Journal of Anaesthesiology 41: 792, 1969

    Google Scholar 

  • Ulmsten U. Inhibition of myometrial hyperactivity by Ca antagonists. Danish Medical Bulletin 26: 125, 1979

    PubMed  CAS  Google Scholar 

  • Vogel JHK, Pryor R, Blount SG. Direct current defibrillation during pregnancy. Journal of the American Medical Association 193: 970–971, 1965

    Article  PubMed  CAS  Google Scholar 

  • Weaver JB, Pearson JF. Influence of digitalis on time of onset and duration of labour in women with cardiac disease. British Medical Journal 3: 519–520, 1973

    Article  PubMed  CAS  Google Scholar 

  • Wolff F, Breuker KH, Schlensker KH, Bolte A. Prenatal diagnosis and therapy of fetal heart rate anomalies: with a contribution on the placental transfer of verapamil. Journal of Perinatal Medicine 8: 203–208, 1980

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sackler School of Medicine, Tel-Aviv University and Edith Wolfson Hospital, Holon, Israel

    Heschi H. Rotmensch, Siegfried Rotmensch & Uri Elkayam

  2. Department of Obstetrics and Gynecology, Michael Reese Hospital, University of Chicago, Chicago, USA

    Heschi H. Rotmensch, Siegfried Rotmensch & Uri Elkayam

  3. University of Southern California/Los Angeles County Medical Center, Los Angeles, USA

    Heschi H. Rotmensch, Siegfried Rotmensch & Uri Elkayam

Authors
  1. Heschi H. Rotmensch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Siegfried Rotmensch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Uri Elkayam
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rotmensch, H.H., Rotmensch, S. & Elkayam, U. Management of Cardiac Arrhythmias during Pregnancy. Drugs 33, 623–633 (1987). https://doi.org/10.2165/00003495-198733060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198733060-00005

Keywords

Search

Navigation